← Leaderboards
Ben Hindson
Quantalife, Inc.
$2,209,749
Attributed
$2,209,749
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.4M · FY2010–11$2M$1.5M$1M$500K$0
'10
'11
Funding mix
By agency
NIH$2,209,749 · 1
By mechanism
R01$2,209,749 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Antibiotic Resistance”
- Clarence Buddy Creech · Vanderbilt University Medical Center$44,308,631
- Deborah T Hung · Massachusetts General Hospital$40,070,450
- Urs Ochsner · Crestone, Inc.$36,950,837
- Ryan Cirz · Revagenix, Inc.$35,410,554
- Scott J Hultgren · Washington University$33,172,142
- Daniel E Kahne · Harvard University$31,193,047
Research focus
Antibiotic ResistanceAreaAntimicrobialBacteriaBaseBedside TestingsAutomationBiologicalCellsClinics And HospitalsClostridium DifficileCommercializationCommunicable DiseasesComputer SoftwareCostBenchmarkingCoupledCytolysisData AnalysesDecontaminationDesignDetectionDiagnosticEffectiveness Measure
Grant awards (4)
Rapid, Cost-Effective Nucleic Acid Testing for Active Surveillance and Molecular$648,892
R01 · FY2011 · EB · contact PI
Rapid, Cost-Effective Nucleic Acid Testing for Active Surveillance and Molecular$427,893
R01 · FY2011 · EB · contact PI
Rapid, Cost-Effective Nucleic Acid Testing for Active Surveillance and Molecular$312,070
R01 · FY2011 · EB · contact PI
Rapid, Cost-Effective Nucleic Acid Testing for Active Surveillance and Molecular$820,894
R01 · FY2010 · EB · contact PI